全文获取类型
收费全文 | 587篇 |
免费 | 50篇 |
国内免费 | 4篇 |
专业分类
妇产科学 | 8篇 |
基础医学 | 17篇 |
口腔科学 | 1篇 |
临床医学 | 36篇 |
内科学 | 3篇 |
神经病学 | 3篇 |
特种医学 | 10篇 |
外科学 | 310篇 |
综合类 | 28篇 |
预防医学 | 8篇 |
药学 | 24篇 |
中国医学 | 2篇 |
肿瘤学 | 191篇 |
出版年
2024年 | 2篇 |
2023年 | 10篇 |
2022年 | 24篇 |
2021年 | 42篇 |
2020年 | 34篇 |
2019年 | 28篇 |
2018年 | 43篇 |
2017年 | 33篇 |
2016年 | 26篇 |
2015年 | 23篇 |
2014年 | 27篇 |
2013年 | 41篇 |
2012年 | 30篇 |
2011年 | 42篇 |
2010年 | 13篇 |
2009年 | 27篇 |
2008年 | 38篇 |
2007年 | 29篇 |
2006年 | 23篇 |
2005年 | 13篇 |
2004年 | 17篇 |
2003年 | 15篇 |
2002年 | 10篇 |
2001年 | 5篇 |
2000年 | 6篇 |
1999年 | 3篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1990年 | 1篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1981年 | 4篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1977年 | 2篇 |
排序方式: 共有641条查询结果,搜索用时 0 毫秒
1.
Transposition of the latissimus dorsi musculocutaneous flap is still considered by most authors a first-choice technique for breast reconstruction. However, the aesthetic drawbacks of the technique are significant: In our experience the posterior scar and the patchlike skin island are of concern to more than 30% of patients. Recent alternatives have sharply reduced the use of the latissimus dorsi myocutaneous flap as our first-choice technique. The utilization of a latissimus dorsi muscular flap in association with submuscular placement of a tissue expander is now our favorite technique for the majority of patients: Residual scarring is insignificant since the whole muscle can be raised through a 5–7-cm-long, S-shaped incision placed along the anterior border of the latissimus dorsi. The results obtained in a group of 35 patients demonstrate that the final results of the procedure in terms of shape and projection of the reconstructed breasts are absolutely similar to those obtained using the latissimus dorsi musculocutaneous flap. However, in patients with heavy body structure and large contralateral breast, satisfactory symmetry and a natural-looking reconstructed breast are obtained more effectively by transposition of a rectus abdominis myocutaneous flap. The precautions to be taken in order to make the procedure suitable for overweight patients are described and the results are discussed. 相似文献
2.
K. Tada M. Yoshimoto S. Nishimura K. Takahashi M. Makita T. Iwase S. Takahashi Y. Ito K. Hatake M. Ueno K. Nakagawa F. Kasumi 《European journal of surgical oncology》2004,30(10):1077-1083
AIM: Large multicenter, randomized trials have revealed the advantages of using tamoxifen for 5 years vs 2 years in breast cancer patients. The aim of this report is to confirm the optimal duration of tamoxifen administration in a study of Japanese breast cancer patients. METHODS: Japanese post-menopausal estrogen receptor-positive breast cancer patients treated with mastectomy were randomly assigned to either a 5-year or 2-year course of tamoxifen. The primary endpoint was disease-free survival, with secondary endpoints of overall survival and a reduction in the development of metachronous contra-lateral breast cancer. RESULTS: A total of 256 breast cancer patients were randomized to a 5-year or 2-year tamoxifen administration group. After a median follow-up time of 81 months, there were no significant differences seen in terms of disease-free or overall survival (p=0.65 and 0.56, respectively). Furthermore, the impact of the 5-year use of tamoxifen on the development of contra-lateral breast cancer did not reach statistical significance (p=0.0511). However, 5-year tamoxifen use was closely associated with gynaecological complications (p=0.0081). CONCLUSION: We could not show a beneficial effect of using tamoxifen for 5 years over 2 years in Japanese estrogen receptor-positive patients. This is likely due to the small number of patients enrolled in our study; however, racial disparity may influence this result. A reevaluation is necessary to study the advantages of the 5-year use of tamoxifen in the Japanese racial subgroup. 相似文献
3.
本文复习了我院72例改良根治术治疗的乳腺癌患者,与同时期Halsted根治术73例作比较。MRM组5年、10年生存率分别为81.04%和50.59%,RM组分别为75.57%和55.33%。经统计学处理,两组无显著性差异(P>0.05)。同时对腋淋巴结清除数目与局部复发率分别进行比较,两组也无显著差异。作者认为对可手术的乳腺癌,除非肿瘤累及胸大肌或腋淋巴结转移较大而影响手术操作外,MRM为可行术式。 相似文献
4.
目的探讨带血管蒂转移皮瓣在乳腺癌术后乳房再造中的安全性和整形效果。方法2004年3月—2010年6月,对37例乳腺肿瘤患者,行乳房切除术后带蒂背阔肌或TRAM皮瓣乳房再造。其中Ⅰ期再造34例,Ⅱ期再造3例;对其中15例TRAM皮瓣再造的供区下腹部应用涤纶补片加强腹壁。结果1例TRAM皮瓣小部分坏死,6例Ⅰ期再造术后乳房本体皮肤坏死。3例背阔肌皮瓣再造发生背部皮下血清肿;3例TRAM皮瓣下腹中段脂肪液化,无腹壁膨隆或腹壁疝发生。随访2月—72月,1例肿瘤局部复发,1例肝转移。乳房外观评价,总体可接受度94.59%。 结论背阔肌或TRAM带血管蒂转移皮瓣再造是乳房切除术后行全乳再造的有效和安全的方法,应用涤纶补片加强腹壁可以有效预防腹壁软弱和腹壁疝形成。 相似文献
5.
早期乳腺癌保乳手术探讨 总被引:2,自引:0,他引:2
目的 探讨早期乳腺癌保乳手术指征、方法及效果。方法对已进行保乳手术的48例患者进行追踪观察手术效果并评价患者的满意度。结果随访3~49个月,无一例局部复发及远处转移,无死亡。外形优良85.4%,心理满意度80%。结论对早期乳腺癌患者行保乳手术兼顾了治疗效果和心理需求;而要达到好的效果,严格掌握手术适应证、手术方法和术后放疗是关键。 相似文献
6.
7.
乳房切除患者对乳房重建态度的调查分析 总被引:32,自引:1,他引:32
目的 :探讨改良根治式乳房切除女患者对乳房重建的态度及其相关因素。方法 :采用问卷调查法对河北省改良根治式乳房切除的 16 0名妇女进行乳房重建相关问题的调查 ,通过百分比构成法、Spearman单因素相关分析和Stepwise多元逐步回归分析对 6 2份调查问卷结果进行统计分析。结果 :被调查者中 ,渴望进行乳房重建者占 41.94% ;渴望乳房重建与自我形象和经济收入呈显著性正相关 ,与年龄呈显著性负相关 ;重建知识来源于本次问卷的患者占 6 7.8% ,而来源于医务工作者的只占 6 .4%。结论 :改良根治式乳房切除患者对乳房重建的态度是积极的 ,但获得的有关信息不足 ,医务工作者应加强宣教工作。 相似文献
8.
目的 探讨月牙形切口在乳腺癌改良根治术中的应用效果.方法 分析近10多年129例行乳腺癌改良根治术的乳腺癌患者的临床资料,129例均行乳腺癌改良根治术.随机分为两组:A组,51例,采用月牙形切口;B组,78例,采用Steward横切口.观察患者的切口愈合情况、腋窝淋巴结清扫的数目、肩关节功能恢复满意度.结结果 A组月切口Ⅰ期愈合率90.2%(46/51),B组75.6%(59/78)(P<0.05);患侧肩关节功能恢复满意度A组96.1%(49/51),B组84.6%(66/78)(P<0.05).结论 月牙形切口张力低,愈合好,暴露满意,对肩关节的功能影响小,是乳腺癌改良根治术的一种理想切口. 相似文献
9.
BackgroundThe objectives of this study were to compare, by patient obesity status, the contemporary utilization patterns of different reconstruction surgery types, understand postoperative complication profiles in the community setting, and analyze the financial impact on health care payers and patients.MethodsUsing data from the MarketScan Health Risk Assessment Database and Commercial Claims and Encounters Database, we identified breast cancer patients who received breast reconstruction surgery following mastectomy between 2009 and 2012. The Cochran-Armitage test was used to evaluate the utilization pattern of breast reconstruction surgery. Multivariable logistic regressions were used to estimate the association between obesity status and infectious, wound, and perfusion complications within one year of surgery. A generalized linear model was used to compare total, complication-related, and out-of-pocket costs.ResultsThe rate of TE/implant-based reconstruction increased significantly for non-obese patients but not for obese patients during the years analyzed, whereas autologous reconstruction decreased for both patient groups. Obesity was associated with higher odds of infectious, wound, and perfusion complications after TE/implant-based reconstruction, and higher odds of perfusion complications after autologous reconstruction. The adjusted total healthcare costs and out-of-pocket costs were similar for obese and non-obese patients for either type of breast reconstruction surgery.ConclusionsA greater likelihood of one-year complications arose from TE/implant-based vs autologous reconstruction surgery in obese patients. Given that out-of-pocket costs were independent of the type of reconstruction, greater emphasis should be placed on conveying the surgery-related complications to obese patients to aid in patient-based decision making with their plastic surgeons and oncologists. 相似文献
10.
《Cirugía espa?ola》2020,98(1):26-35
IntroductionThe use of ambulatory surgery (AS) for breast pathology (BP) has increased. The objective of this study is to analyse a group of patients treated surgically for breast pathology in order to evaluate its quality and security in a MAS setting in 2017.MethodsA retrospective review of all patients undergoing breast surgery was conducted within an AS programme from January to December 2017 in Consorcio Hospital General Universitario of Valencia (CHGUV). The study analysed the number of patients, exclusion reasons, type of surgical procedures, evolution of substitution rate (SR), rate and causes of conversion to admission, postoperative complications, motives for not being included in the ambulatory programme and the satisfaction rate of the patients treated with ambulatory surgery. This has been compared with a 2013 group.ResultsIn 2017, 396 procedures for BP were performed: 170 for benign and 226 for malignant disease. The SR for the global mammary pathology was 72.8%. The SR for benign pathology was 93.4% and the SR for malignant pathology was 57.2%, which has increased in recent years from 45.4% in 2013. The unexpected hospitalization rate (HR) of malignant pathologies was 14.1%, while the HR in benign pathologies was 0.6%. Patients hospitalized for malignant pathologies presented higher complications (17%) than ambulatory patients (8.5%) and benign pathologies (6.5%).ConclusionsAt the CHGUV, the SR has steadily increased in malignant pathologies. The unexpected hospitalization rate is determined by perioperative sentinel lymph node biopsy results. AS for the treatment of mammary pathology is efficient and safe. 相似文献